Clinical efficacy and safety of Ceraxon® for treatment of primary open-angle glaucoma

M A Frolov; Фролов Михаил Александрович; P A Gonchar; Гончар Петр Андреевич; V I Barashkov; Барашков Владимир Иванович; V Kumar; Кумар Винод; N S Morozova; Морозова Наталья Степановна; A M Frolov; Фролов Александр Михайлович; K A Kazakova; Казакова Ксения Александровна

Clinical efficacy and safety of Ceraxon® for treatment of primary open-angle glaucoma

Authors: Frolov MA¹, Gonchar PA¹, Barashkov VI¹, Kumar V¹, Morozova NS¹, Frolov AM¹, Kazakova KA¹
Affiliations:
1. Peoples, Friendship University of Russia
Issue: No 2 (2012)
Pages: 100-103
Section: Articles
URL: https://journals.rudn.ru/medicine/article/view/3118
ID: 3118

Cite item

Full Text

Abstract
About the authors
References
Supplementary files
Statistics

Abstract

35 patients with primary open-angle glaucoma (POAG) with unstabilized clinical course and normalized intraocular pressure were treated. All patients were divided into subgroups: 8 patients - with the Ist stage of POAG, 12 - with the IInd and 15 with stage III-IV. Patients were examined with clinical-ophthalmologic and instrumental methods. After the treatment by CERAXON® an improvement of visual functions were noted, accompanied by significant positive dynamics of perimetric and morphometric characteristics: average light sensitivity and defect, dispersion, average thickness of retinal nerve fiber layer. During the treatment by CERAXON® there wasn't any case of side effects, demanding drug withdrawal or change of therapeutic regimen.

Keywords

CERAXON, Citikolin, glaucoma, dispersion, glaucoma optic neuropathy

References

Supplementary files

Supplementary Files

Action

1. JATS XML

Download

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

Clinical efficacy and safety of Ceraxon® for treatment of primary open-angle glaucoma

Full Text

Abstract

Keywords

About the authors

References

Supplementary files